| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0000700 | Intron-Exon-Intron | chr20:35003887-35071180 | chr20:36375484-36442777 | 250 nt | 0.4560 |
| hsa_DLGAP4_0000800 | Intron-Exon-Intron | chr20:35003887-35075340 | chr20:36375484-36446937 | 250 nt | 0.4800 |
| hsa_DLGAP4_0000900 | Intron-Exon-Intron | chr20:35003887-35129014 | chr20:36375484-36500611 | 250 nt | 0.4280 |
| hsa_DLGAP4_0001200 | Intron-Intron | chr20:35020820-35026719 | chr20:36392417-36398316 | 113 nt | 0.4956 |
| hsa_chr20_0113200 | Intergenic-Intergenic | chr20:35021060-35027311 | chr20:36392657-36398908 | 250 nt | 0.3880 |
| hsa_chr20_0113300 | Intergenic-Intergenic | chr20:35040343-35040600 | chr20:36411940-36412197 | 258 nt | 0.4690 |
| hsa_DLGAP4_0001400 | Intron-Intron | chr20:35046794-35049100 | chr20:36418391-36420697 | 2307 nt | 0.5167 |
| hsa_DLGAP4_0001500 | Intron-Exon-Intron | chr20:35051922-35091002 | chr20:36423519-36462599 | 250 nt | 0.4360 |
| hsa_DLGAP4_0001600 | Exon-Exon | chr20:35060049-35061119 | chr20:36431646-36432716 | 1071 nt | 0.6536 |
| hsa_DLGAP4_0001700 | Exon-Exon | chr20:35060049-35064753 | chr20:36431646-36436350 | 1313 nt | 0.6679 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].